National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 8) (PB 87 of 2018) (Cth)

PB 87 of 2018

National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 8)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated        25  September 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 8).

(2)   This Determination may also be cited as PB 87 of 2018.

1. Commencement

This Determination commences on 1 October 2018.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Empagliflozin

Omit

Emtricitabine

Insert

Emtricitabine with tenofovir alafenamide

[2]     Schedule 1, after item dealing with Indacaterol

Omit

Indinavir

[3]     Schedule 1, after item dealing with Isoniazid

Omit

Ivabradine

[4]     Schedule 1, after item dealing with Mifepristone and misoprostol

Omit

Milk powder—lactose free formula

[5]     Schedule 1, after item dealing with Nafarelin

Omit

Nandrolone decanoate

[6]     Schedule 1, after item dealing with Tenecteplase

Insert

Tenofovir alafenamide with emtricitabine, elvitegravir and cobicistat

[7]     Schedule 2, after item dealing with Itraconazole

Insert

Ivabradine